Stay updated on PM01183 Escalating Doses with Doxorubicin Clinical Trial
Sign up to get notified when there's something new on the PM01183 Escalating Doses with Doxorubicin Clinical Trial page.

Latest updates to the PM01183 Escalating Doses with Doxorubicin Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision entry labeled v3.3.3 was added, and the entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the Record History page; this is a minor site update with no changes to study details.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the banner notice about a lapse in government funding and operating status guidance on the page.SummaryDifference0.7%

- Check69 days agoChange DetectedThe new screenshot shows the same version history entries with only minor formatting adjustments; no core study data or status information appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check97 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference12%

- Check104 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0; previous version tag removed and new version tag added.SummaryDifference0.3%

Stay in the know with updates to PM01183 Escalating Doses with Doxorubicin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PM01183 Escalating Doses with Doxorubicin Clinical Trial page.